VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EVO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EVOEvotec SE
$1.69$600M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. EVO
  4. Financial Ratios

Evotec SE (EVO) Financial Ratios

Latest Ratios: P/E Ratio -2.9x · EV/EBITDA N/A · ROE -11.3%. (2003–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

EVO Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$600M$1.1B$1.5B$4.2B$2.9B$7.9B$5.6B$3.8B$2.9B$2.3B$1.0B
Enterprise Value$633M$1.1B$1.6B$4.5B$3.0B$7.7B$5.7B$4.1B$2.9B$2.5B$976M
P/E Ratio →-2.93————36.54917.5098.8535.57100.3738.90
P/S Ratio0.751.441.855.313.8012.7911.268.627.839.046.27
P/B Ratio0.661.341.553.712.415.746.377.196.917.024.82
P/FCF————116.902399.60—373.1922.89—18.02
P/OCF——80.96113.9113.8964.66126.1891.1518.80215.0815.30

P/E links to full P/E history page with 30-year chart

EVO EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—1.482.025.703.9512.4911.439.097.849.525.93
EV / EBITDA———97.9828.5069.2854.7536.4227.0642.0822.57
EV / EBIT—————31.34166.96106.8739.4691.4028.31
EV / FCF————121.232343.01—393.4422.93—17.06

EVO Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin8.3%8.3%14.4%22.4%23.2%24.5%25.1%29.8%29.8%32.0%35.6%
Operating Margin-17.9%-17.9%-17.9%-6.1%2.8%6.6%9.7%14.0%20.6%14.6%19.1%
Net Profit Margin-13.1%-13.1%-24.6%-10.7%-23.4%34.9%1.3%8.5%22.4%9.4%16.7%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-11.3%-11.3%-18.9%-7.3%-13.7%19.0%0.9%7.9%22.2%8.9%13.7%
ROA-5.4%-5.4%-9.4%-3.7%-7.8%10.6%0.4%3.5%11.7%4.8%8.6%
ROIC-10.5%-10.5%-8.5%-2.6%1.3%2.8%4.2%8.0%13.1%9.2%14.5%
ROCE-9.1%-9.1%-8.5%-2.6%1.1%2.3%3.5%7.1%15.5%10.7%12.3%

EVO Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.550.550.470.730.430.370.680.970.270.570.13
Debt / EBITDA———17.934.874.605.754.671.053.260.67
Net Debt / Equity—0.040.140.270.09-0.140.100.390.010.37-0.26
Net Debt / EBITDA———6.701.02-1.670.811.870.052.11-1.27
Debt / FCF————4.33-56.59—20.260.04—-0.96
Interest Coverage-7.89-7.89-15.58-5.87-10.7126.614.055.0928.7921.2722.63

EVO Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio2.072.071.981.943.183.393.162.621.270.732.31
Quick Ratio1.991.991.891.883.093.313.102.561.240.702.25
Cash Ratio1.291.291.151.302.092.652.311.790.760.411.74
Asset Turnover—0.430.420.350.330.280.270.320.490.390.47
Inventory Turnover23.7023.7021.9219.6319.3618.0922.5725.9946.5419.4124.61
Days Sales Outstanding—102.87100.02103.65133.95104.39122.03113.9259.2599.1466.18

EVO Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield—————2.7%0.1%1.0%2.8%1.0%2.6%
FCF Yield————0.9%0.0%—0.3%4.4%—5.5%
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Total Shareholder Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Shares Outstanding—$355M$355M$354M$353M$333M$308M$299M$295M$290M$265M

Key Metrics

Growth RegimeDecelerating
ProfitabilityWeak
Balance SheetAdequate
Cash FlowDeteriorating
Top Statement Risk

Persistent negative operating margins

Margin Collapse Signals Structural Misalignment

Evotec's gross margin has deteriorated from a healthy 31.0% in Q4 2025 to negative territory in both Q1 and Q2 2026, indicating that cost of goods sold is now exceeding revenue in recent periods.

The shift to negative gross margins suggests a severe underutilization of the company's high-fixed-cost infrastructure, particularly the J.POD facilities, or a shift toward lower-margin manufacturing services. This structural stress is compounded by operating margins that have plunged to -35.6% in Q2 2026, indicating that the current revenue base is fundamentally insufficient to cover the heavy R&D and administrative overhead required to maintain its technological platform.

Capital Compounding Has Turned to Value Destruction

Based on reported figures, Evotec's ROIC has swung from a positive 1.8% in Q4 2025 to a negative -5.2% in Q2 2026, indicating the company is now destroying value on the capital invested in its platform.

This negative return on invested capital is driven by the collapse in operating profitability, not just asset efficiency. The trend suggests that the significant capital deployed into the J.POD and PanOmics platforms is not generating commensurate returns, and the business model may require a fundamental shift toward higher-margin milestone and royalty income to reverse this decay.

Working Capital Volatility Masks Underlying Inefficiency

As reported in financial statements, Evotec's cash conversion cycle has expanded to 83 days in Q2 2026 from 60 days in Q4 2025, driven by a sharp increase in days sales outstanding to 93 days.

The lengthening DSO suggests potential collection challenges or a shift in customer mix toward slower-paying partners, which is concerning given the revenue decline. This working capital drag is consuming liquidity at a time when the company is already burning cash, as evidenced by the -82.0% FCF margin, and indicates a need for tighter management of receivables to preserve cash.

Leverage Creeps Higher on Cash Burn

According to recent SEC filings, Evotec's debt-to-equity ratio has increased to 0.71 in Q2 2026 from 0.55 maintained for several quarters, indicating a shift toward necessity-driven financing as cash reserves are consumed.

While the absolute leverage level remains moderate, the trajectory is a concern. The increase in total debt to $475.9M coincides with a period of negative operating cash flow and a deteriorating equity base, suggesting that future capital raises may become necessary if the path to profitability remains elongated, potentially leading to shareholder dilution.

The Misleading Safety of the Current Ratio

The current ratio of 2.33 in Q2 2026 appears robust but is likely misapplied to this business model, as it obscures the severe cash burn rate and the potential for rapid liquidity deterioration.

For a company with a -82.0% FCF margin and a collapsing revenue base, the current ratio is a poor indicator of financial health. It fails to account for the speed at which cash is being consumed and the risk that the asset base, particularly inventory and receivables, may not be convertible to cash quickly enough to meet obligations if the operational trajectory does not improve. A more appropriate metric would be the cash runway based on the current burn rate.

Download Financial Ratios Data

Includes 30+ ratios · 23 years · Updated daily

Consensus & Technical Research Suite
Open EVO Terminal

EVO Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

EVO — Frequently Asked Questions

Quick answers to the most common questions about buying EVO stock.

What is Evotec SE's P/E ratio?

Evotec SE's current P/E ratio is -2.9x. The historical average is 77.0x.

What is Evotec SE's ROE?

Evotec SE's return on equity (ROE) is -11.3%. The historical average is -7.9%.

Is EVO stock overvalued?

Based on historical data, Evotec SE is trading at a P/E of -2.9x. Compare with industry peers and growth rates for a complete picture.

What are Evotec SE's profit margins?

Evotec SE has 8.3% gross margin and -17.9% operating margin.